| Filed On | Filing |
|---|---|
| 18 May 2026 |
Form 3: Glancy Donovan Michael, Director
No securities owned |
| 15 Aug 2025 |
Form 3: Rubric Capital Management Lp, 10% owner and 1 other
Holds 3,157,743 shares of Common stock, par value $0.001 per share |
| 19 May 2025 |
Form 3: Paya Carlos V, Director
No securities owned |
| 19 Mar 2025 |
Form 3: Dieter David, EVP & General Counsel
No securities owned |
| 05 Feb 2025 |
Form 3: Lurker Nancy, Director
No securities owned |
| 14 Nov 2024 |
Form 3: Karnani Vikram, Director
No securities owned |
| 08 Apr 2022 |
Form 3: McFarlane Neil F., Director
Holds 0 shares of No securities beneficially owned |
| 01 Apr 2022 |
Form 3: Smith Thomas B, EVP and Chief Medical Officer
Holds 0 shares of No securities beneficially owned |
| 24 May 2021 |
Form 3: Tupper Colleen, EVP & Chief Financial Officer
Holds 0 shares of No securities beneficially owned |
| 28 Sep 2020 |
Form 3: Balice-Gordon Rita J., Director
Holds 0 shares of No securities beneficially owned |
| 02 Apr 2019 |
Form 3: Malamut Richard, EVP and Chief Medical Officer
Holds 0 shares of No securities beneficially owned |
| 12 Jul 2018 | Form 3: Dreyer Scott, EVP & Chief Commercial Officer |
| 26 Mar 2018 |
Form 3: Kuhlmann Shirley R., EVP and General Counsel
Holds 0 shares of No securities beneficially owned |
| 11 Aug 2017 |
Form 3: Melincoff Gwen A, Director
Holds 0 shares of No securities beneficially owned |
| 02 Jun 2017 |
Form 3: Ciaffoni Joseph, Chief Operating Officer
Holds 0 shares of No securities beneficially owned |
| 17 Jan 2017 |
Form 3: Fleming Alison B, Chief Scientific Officer
Holds 7,211 shares of Common Stock |
| 13 Jun 2016 |
Form 3: Fallon John A., Director
Holds 0 shares of No securities benefically owned |
| 26 Jan 2016 |
Form 3: Schroeder Theodore R, Director
Holds 0 shares of No securities beneficially owned |
| 08 May 2015 | Form 3: Longitude Capital Partners, Llc, 10% owner and 4 others |
| 06 May 2015 | Form 3: Tpg Group Holdings (SBS) Advisors, Inc., 10% owner and 2 others |
Loading...
